Dr. David Becker Discusses New Cholesterol-Lowering Medication in Philadelphia Inquirer Column

David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about a new medication called bempedoic acid (Nexletol) that was approved by the U.S. Food and Drug Administration as a novel way to lower cholesterol.